Potential for immunotherapy with heat-killed Mycobacterium vaccae in respiratory medicine.

@article{Stanford2009PotentialFI,
  title={Potential for immunotherapy with heat-killed Mycobacterium vaccae in respiratory medicine.},
  author={John Lawson Stanford and Cynthia Stanford and Diana G Dlugovitzky and Gladys Fiorenza and Diego Martinel-Lamas and Dante A Selenscig and Christina Bogue},
  journal={Immunotherapy},
  year={2009},
  volume={1 6},
  pages={
          933-47
        }
}
Immunotherapy with Mycobacterium vaccae has been shown to be beneficial as part of the treatment for a wide range of diseases. In the respiratory system, the late airway response in bronchial asthma is modified by a single dose and bronchial aspects of hayfever are reduced allowing a major reduction in the use of bronchial dilators. In studies of advanced adenocarcinoma of the lung survival is increased by an average of 4 months when up to five doses of M. vaccae are added to the course of… CONTINUE READING
BETA